Data / Research funding / North Carolina / PPD Development LP
PPD Development LP: 19 NIH awards ($777.2M), fiscal years 2021 to 2026
PPD Development LP in Wilmington, NC is funded under 19 NIH awards ($777.2M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- ZANENSW6C665
- State
- North Carolina
Awards
19 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $417,904,831 | August 15, 2023 | August 14, 2024 | STROKES, BAMBRA | reporter.nih.gov |
| HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $198,645,463 | August 15, 2025 | August 14, 2026 | STOKES, BAMBRA | reporter.nih.gov |
| NIAID CLINICAL SITE MONITORING | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $68,539,045 | February 1, 2023 | January 31, 2024 | SMITH, KIMBERLY | reporter.nih.gov |
| NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $28,578,960 | June 30, 2022 | June 29, 2025 | GLESSNER, MARY | reporter.nih.gov |
| PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $26,732,375 | June 12, 2023 | April 30, 2028 | SEVER, MICHELLE LYNN | reporter.nih.gov |
| REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $14,546,225 | August 1, 2023 | October 31, 2025 | KIRKBY, MATTHEW | reporter.nih.gov |
| DAIT CLINICAL SITE MONITORING CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,026,060 | January 1, 2012 | March 31, 2022 | GLESSNER, MARY | reporter.nih.gov |
| Clinical Trial Site Monitoring for PHOENIx MDR-TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,653,435 | April 15, 2025 | December 14, 2025 | SMITH, KIMBERLY | reporter.nih.gov |
| Task A: Early Phase Clinical Trial Units (EPCTU) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,513,839 | January 14, 2022 | January 13, 2026 | PALLEJA, SANDRA | reporter.nih.gov |
| REGULATORY MANAGEMENT CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $3,340,391 | November 1, 2011 | October 31, 2021 | SCHULLER, CHARITY-ANNE | reporter.nih.gov |
| \SINGLE ASCENDING DOSE (SAD) PHASE I STUDY | NIH | National Institute on Drug Abuse | 2022 to 2024 | $3,187,404 | July 8, 2016 | June 30, 2026 | BOYLE, CRAIG | reporter.nih.gov |
| CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,226,376 | September 28, 2023 | September 27, 2025 | KIRBY, MATTHEW | reporter.nih.gov |
| Clinical Site and Study Monitoring Support Services for the National Heart, Lung, and Blood Institute's Hypertension Outcomes for T4 Research within Lower Middle-Income Countries (Hy-TREC) - Option Pe | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $386,711 | April 26, 2019 | April 25, 2023 | OLTMAN, LISA | reporter.nih.gov |
| CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH. | NIH | National Institute on Drug Abuse | 2021 to 2023 | $345,218 | September 26, 2023 | September 25, 2024 | CROUSE, CELESTE | reporter.nih.gov |
| HEAL - RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $304,881 | June 17, 2024 | June 16, 2029 | reporter.nih.gov | |
| CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. REGULATORY PATHWAY AND MARKET ACCESS SUPPORT. TASK ORDER 03. 04/09/2024 - 04/ | NIH | National Institute on Drug Abuse | 2024 | $169,638 | April 9, 2024 | April 8, 2029 | KIRKBY, MATTHEW | reporter.nih.gov |
| HUB Clinical Trials Monitoring (OCR) | NIH | National Institute on Drug Abuse | 2021 | $26,846 | May 26, 2021 | May 25, 2022 | KIRBY, MATTHEW | reporter.nih.gov |
| CLINICAL CENTRAL LABORATORY SERVICES | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $25,000 | May 13, 2021 | May 12, 2026 | KIRKBY, MATTHEW | reporter.nih.gov |
| TO 1A Project Kick-Off Meeting | NIH | National Cancer Institute | 2022 | $2,245 | August 1, 2022 | October 31, 2022 | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7 | $53,187,800 | 0 | $0 |
| 2024 | 9 | $56,719,759 | 0 | $0 |
| 2023 | 12 | $57,690,848 | 0 | $0 |
| 2022 | 13 | $185,796,233 | 0 | $0 |
| 2021 | 8 | $423,760,303 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 1 award here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
Topics of its NIH awards
- Clinical Research
- Clinical Trials and Supportive Activities
- Infectious Diseases
- Prevention
- HIV/AIDS
- Immunization
- Vaccine Related
- Translational Research
- Mental Health
- Neurosciences
- Vaccine Related (AIDS)
- Emerging Infectious Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.